Featured Research

from universities, journals, and other organizations

Women With Atrial Fibrillation Face A Higher Risk Of Ischemic Stroke Than Men

Date:
September 19, 2005
Source:
University of California - San Francisco
Summary:
Women with atrial fibrillation who are not on anticoagulant therapy have a higher rate of ischemic stroke and face a higher absolute risk for stroke than do men with the condition, according to a joint study by researchers at the University of California, San Francisco, Massachusetts General Hospital, the Division of Research at Kaiser Permanente and Boston University School of Medicine.

Women with atrial fibrillation who are not on anticoagulant therapyhave a higher rate of ischemic stroke and face a higher absolute riskfor stroke than do men with the condition, according to a joint studyby researchers at the University of California, San Francisco,Massachusetts General Hospital, the Division of Research at KaiserPermanente and Boston University School of Medicine.

Using a sample of 13,559 patients with atrial fibrillation, or rapidirregular contractions of the heart, researchers compared the rates ofischemic stroke between men and women and examined the efficacy andcomplications associated with a common blood thinner, Warfarin. Theirfindings are being reported in the September 20 issue of Circulation.

Warfarin is well known to be effective in reducing the risk ofstroke in persons with atrial fibrillation; however prior studies haveprovided conflicting evidence about whether women with atrialfibrillation have a higher risk for stroke than men when not takingblood thinners. "The research from this study clearly shows that genderplays a role in ischemic stroke risk and occurrence," said lead authorMargaret Fang, MD, MPH, assistant adjunct professor of medicine, andhospitalist at UCSF Medical Center.

The higher incidence of stroke in women not taking Warfarintherapy occurred among women in all stroke-risk-factor categories,including those with prior stroke, hypertension, congestive heartfailure, coronary artery disease and diabetes. Because of thesignificant differences in the rate of stroke between men and women,the study indicates that being a woman is an independent risk factorfor stroke and should be considered when choosing treatment options forwomen with atrial fibrillation.

According to the researchers, atrial fibrillation is the mostcommon cardiac arrhythmia, and a major risk factor for both ischemicstroke and peripheral embolism, an obstruction of the blood supply toan organ. Anticoagulation therapies, such as Warfarin, are well knownto substantially reduce the risk of atrial fibrillation-related strokeand embolism, but also have been shown to increase the risk forhemorrhage. "Because of this increased hemorrhage risk, physicians aresometimes hesitant to prescribe the drug, and some studies have shownthat women are less likely to receive warfarin therapy than men," Fangsaid. "However, we found that women in our study did not sufferbleeding complications related to Warfarin more often than men who wereusing the therapy."

Furthermore, data showed that women may actually benefit morefrom Warfarin because of their higher baseline risk for stroke. "Womenwith atrial fibrillation, particularly those with other risk factorsfor stroke, should be especially encouraged to take Warfarin," Fangadded.

###

The researchers used data from Kaiser Permanente's AnTicoagulationand Risk Factors In Atrial Fibrillation (ATRIA) Study cohort. The studywas supported by a Public Health Services research grant from theNational Institutes on Aging and the Eliot B. and Edith C. ShoolmanFund of Massachusetts General Hospital.


Story Source:

The above story is based on materials provided by University of California - San Francisco. Note: Materials may be edited for content and length.


Cite This Page:

University of California - San Francisco. "Women With Atrial Fibrillation Face A Higher Risk Of Ischemic Stroke Than Men." ScienceDaily. ScienceDaily, 19 September 2005. <www.sciencedaily.com/releases/2005/09/050919082741.htm>.
University of California - San Francisco. (2005, September 19). Women With Atrial Fibrillation Face A Higher Risk Of Ischemic Stroke Than Men. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2005/09/050919082741.htm
University of California - San Francisco. "Women With Atrial Fibrillation Face A Higher Risk Of Ischemic Stroke Than Men." ScienceDaily. www.sciencedaily.com/releases/2005/09/050919082741.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins